In a potential drug development game-changer, a major advance in combating Covid-19 has shown great promise in clinical trials. Per the Associated Press, “Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared, the drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection.” Normally, treatments that transition from needle vaccinations to pill form gain wider adoption by the public, not to mention greater profits for the company that develops it. https://bit.ly/3mjbsqy